Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Intestinal Neoplasms × Polyethylene Glycols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 7 Colonic Neoplasms 5 Colonic Polyps 4 Inflammatory Bowel Diseases 3 Surgical Wound Infection 1 Sarcoma 1 Rectal Neoplasms 1 Opioid-Induced Constipation 1 Neoplasms 1 Melanoma 1 Intestinal Neoplasms 1 Gastrointestinal Hemorrhage 1 Diverticulitis 1 Cancer Pain 1 Adenoma 1

Interventions

Irinotecan 3 Fluorouracil 3 Bevacizumab 3 Oxaliplatin 2 Leucovorin 2 Capecitabine 2 Bisacodyl 2 Aspirin 2 lutetium Lu 177 dotatate 1 guadecitabine 1 copper dotatate CU-64 1 camrelizumab 1 apatinib 1 XELOX 1 Ursodeoxycholic Acid 1 Trastuzumab 1 Simvastatin 1 Radiotherapy 1 Polyethylene Glycols 1 Oviposition 1 Lutetium-177 1 Lutetium 1 Ileostomy 1 Drainage 1 Cyclophosphamide 1 Colonoscopy 1 Chemoradiotherapy 1 Celecoxib 1 Cathartics 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01887158 2014-06-17

PEGOP

Ospedale Santa Maria delle Croci

Phase 4 Completed

Intestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡